Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
8.17
+0.14 (1.74%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Zenas BioPharma Employees
Zenas BioPharma had 130 employees as of December 31, 2024.
Employees
130
Change
n/a
Growth
n/a
Revenue / Employee
$38,462
Profits / Employee
-$1,207,600
Market Cap
341.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 130 | - | - |
ZBIO News
- 8 days ago - Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress - Benzinga
- 11 days ago - Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases - GlobeNewsWire
- 2 months ago - Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 4 months ago - Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) - GlobeNewsWire
- 5 months ago - Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 6 months ago - Zenas BioPharma Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering - GlobeNewsWire